How can you tell if retatrutide is fake?

By the certificate, not by appearance. Lyophilised peptide looks the same regardless of what it is. Look for mass spectrometry confirming identity, a content determination for quantity, and a batch number matching the vial.

Does a high purity figure mean it is genuine?

No. Purity by HPLC measures homogeneity, not identity — a clean peak of the wrong molecule reports as high purity. Identity requires mass spectrometry.

What should a certificate of analysis contain?

A batch number matching the vial, an HPLC purity figure, a mass spectrometry result confirming identity, and a content determination for quantity. Certificates reporting only purity leave two of the three questions unanswered.

Retatrutide Research

Fake Retatrutide and What a Certificate Can Prove

JMWritten & reviewed by Jack Muncaster · Founder, UK PeptidesLast reviewed 2026-08-312 cited sources

A certificate of analysis answers up to three separate questions — identity, purity and quantity — and many answer only purity. HPLC shows one dominant peak but cannot say which molecule it is; mass spectrometry establishes identity; quantity requires a separate determination against a reference standard.

Key facts

Purity: HPLC area percent
Identity: Requires mass spectrometry
Quantity: Separate determination
Common gap: Purity reported, identity assumed
Batch matching: Certificate must name the vial's batch

Purity and identity are not the same test

An HPLC trace showing 99% area under one peak establishes that the material is overwhelmingly one substance. It does not establish which substance. Any peptide of similar hydrophobicity elutes in a similar place, and a truncated or scrambled sequence can look clean. Purity without identity is a statement about homogeneity, not about what you have.

What mass spectrometry adds

A mass spectrum measures molecular weight directly. For retatrutide, an observed mass consistent with the expected value is the single most informative line on a certificate, because it distinguishes the intended molecule from a clean impostor. A certificate reporting only UV purity has not answered the identity question at all.

Research material referenced

Retatrutide 10mg — third-party HPLC tested

View — £59.99

Quantity is the one most often quietly missed

Content determination — how much peptide is actually in the vial — is a third measurement, and it is where certificates most often fall short of their own stated specification. It matters because a vial can be pure, correctly identified, and still contain materially less than its label states.

The certificate has to belong to the vial

A generic certificate for the compound proves nothing about the container in front of you. The document should name a batch, and that batch should be the one printed on the vial. Batch-matched documentation is the difference between a certificate and a brochure.

Extended research context

The Retatrutide Research deep dive

Deep dive: how the triple-agonist scaffold was engineered

Retatrutide's 39-residue backbone was designed by Eli Lilly's peptide chemistry team to preserve the pharmacophores of three glucagon-family receptors on a single chain. The N-terminal domain retains GIP-receptor contacts, mid-chain substitutions restore GLP-1-receptor affinity lost in native GIP, and additional residue swaps confer glucagon-receptor engagement. A γGlu-2xOEG linker anchors a C20 fatty diacid at Lys17, which reversibly binds serum albumin and slows renal clearance — the same albumin-tethering strategy Novo Nordisk pioneered with semaglutide and Lilly refined further in tirzepatide.

The TRIUMPH Phase 3 programme in context

TRIUMPH is Lilly's global Phase 3 development umbrella for retatrutide, spanning obesity (TRIUMPH-1 through TRIUMPH-4), type 2 diabetes, MASH (metabolic dysfunction-associated steatohepatitis), and knee osteoarthritis linked to obesity. Readouts began in 2025 and continue through 2026. Because the compound is investigational, no regulator — FDA, EMA, or MHRA — has issued marketing authorisation, and legitimate supply exists only for laboratory reference and research contexts, never for human administration.

How retatrutide differs from tirzepatide and semaglutide at the mechanism level

Semaglutide is a mono-agonist (GLP-1 only). Tirzepatide is a dual agonist (GIP + GLP-1). Retatrutide adds glucagon-receptor activity, which pre-clinical and Phase 2 data suggest contributes to energy expenditure in addition to appetite regulation and glucose-dependent insulin release. This three-receptor combination is why retatrutide is sometimes called a 'metabolic multi-tool' peptide in the trade press — but the pharmacology is more nuanced than the label implies.

Research applications

▸In vitro receptor-binding assays across GIP-R, GLP-1R and GCGR panels
▸Comparator studies alongside semaglutide, tirzepatide and liraglutide reference standards
▸Analytical-method development: HPLC retention profiling and LC-MS confirmation
▸Stability testing of lipidated 39-residue peptides in aqueous and lyophilised forms
▸Reference material for teaching incretin pharmacology in university-level courses

Handling checklist

✓Store lyophilised vials at −20 °C; protect from light and humidity
✓Reconstitute with bacteriostatic water; avoid vortexing (foams the peptide)
✓Once reconstituted, store at 2–8 °C and use within 28 days
✓Verify batch CoA — HPLC ≥98%, mass matches ~4,731 Da, endotoxin low
✓Do not administer to humans or animals — research use only

Common research-handling mistakes

Learnt from thousands of researcher orders across our UK labs.

✗ Confusing retatrutide with tirzepatide in supplier catalogues

Fix: Cross-check the LY code (LY3437943 = retatrutide; LY3298176 = tirzepatide) and the receptor profile on the CoA.

✗ Using tap or filtered water for reconstitution

Fix: Only use bacteriostatic water for injection (0.9% benzyl alcohol) or sterile water — never lab DI water.

✗ Storing reconstituted solution at room temperature

Fix: Refrigerate at 2–8 °C immediately after reconstitution; discard after 28 days.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Frequently asked questions

How can you tell if retatrutide is fake?: By the certificate, not by appearance. Lyophilised peptide looks the same regardless of what it is. Look for mass spectrometry confirming identity, a content determination for quantity, and a batch number matching the vial.
Does a high purity figure mean it is genuine?: No. Purity by HPLC measures homogeneity, not identity — a clean peak of the wrong molecule reports as high purity. Identity requires mass spectrometry.
What should a certificate of analysis contain?: A batch number matching the vial, an HPLC purity figure, a mass spectrometry result confirming identity, and a content determination for quantity. Certificates reporting only purity leave two of the three questions unanswered.

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

Written and reviewed by

Jack Muncaster · Founder, UK Peptides

Jack founded UK Peptides in Manchester after repeatedly receiving research compounds with missing or recycled paperwork. He is responsible for supplier selection, batch release decisions and the content published in this research library. Every article here is sourced to primary literature and every product page to a signed third-party certificate.

How we write and check this content Report a factual error in this article

Popular across the research hub

One flagship guide from every other research category — keep exploring.

← Back to Forum